Pre-product · research phase · est. 2026

There is no product yet. That's on purpose.

Our•mula is a skincare brand for melanin-rich skin being built the slow way — ingredient research first, community brief second, formula last. Before anything gets made, we're collecting what melanin girlies actually deal with. Add yours.

Where we are right now Reading the literature on hyperpigmentation, post-inflammatory marks, and barrier repair in Fitzpatrick IV–VI skin — the tones most clinical trials skipped. Every entry below becomes a line in the formulation brief. No product yet, and no treatment claims.

The gap

What the aisle got wrong for skin like ours

01

Tested on other skin

Most legacy formulas were validated on a narrow slice of skin tones. Melanin-rich skin responds differently to actives, to irritation, and to sun — and it wasn't in the room.

02

"Brightening" as a euphemism

Too much of this category quietly sells lightening. We're not interested in changing your color. Even tone, healthy barrier, less scarring — same brown skin.

And this isn't only a twenty-something's problem. The same concerns follow us into our thirties, forties, and past — if that's your skin, this is for you too.

03

Diluted for margin

Actives listed at the bottom of the INCI, present in trace amounts, priced like they aren't. The jar runs out before anything changes.

04

Priced out of reach

Thirty dollars, every month, forever, is not a skincare routine. It's a subscription to hoping. Affordability is a formulation constraint here, not a discount.

Asiyah Birashk, founder of Our•mula

Asiyah Birashk — founder

Who's building it

An aerospace engineer who got tired of guessing.

I'm Asiyah. I'm an Afghan American aeronautical engineer — I studied at Berkeley and Purdue, and I now work at an aerospace company, where my whole job is taking a system that isn't performing, finding the actual reason, and fixing that reason instead of the symptom.

I'd used the same moisturizer for a year and my skin still felt stagnant. So I did what I do with everything: I stopped and asked why. Why this product? Why had I been loyal to it for a year without questioning it once?

The brand was never built on testing with skin like mine. I'd been loyal to a brand that never chose me first.

Brown skin, South Asian skin, MENA skin, Black skin — an enormous share of the world, treated as an afterthought by an industry that had the research budget to know better. That's not a mystery. That's a problem nobody bothered to solve.

So I'm solving it, and I'm doing it in the open. No lab door, no reveal. I'll show you the papers I'm reading, the ingredients I'm evaluating, what a formulation actually costs, and why. I don't want to build this for you. I want to build it with you — which is why the first thing on this site isn't a product page. It's a question.

Afghan American Aeronautical engineer UC Berkeley Purdue Building in public

How we work

Three things that won't move

Rigor is non-negotiable

Every ingredient has to earn its line on the label with published evidence in melanin-rich skin, not marketing copy. If the research isn't there, we say so instead of implying it is.

The community holds the pen

Texture, finish, scent, size, price, and which concern we tackle first are decided by the people this is for. You'll see the votes, and you'll see what we did with them.

Her results over our margins

Actives at concentrations that do something, in a jar that lasts, at a price you can pay every month. When the cost breakdown is uncomfortable, we'll publish it anyway.

The skin study

Tell us what your skin is actually dealing with

This tells us which concerns to formulate for first. It isn't a consultation, and we can't tell you what's going on with your skin — for that, please see a dermatologist.

What happens next: your answers join the running totals below, and when we pick the first concern to formulate for, we'll show you the numbers behind the decision.

What the study is saying so far

0 entries logged · updates the moment you add yours

Add yours

Live totals from everyone who's answered. Reported in aggregate only — never names or emails.

Step 1 of 2 · takes about 20 seconds

So we can tell you what your answers changed. No selling, no daily blasts.

That's the essential part — your answer is counted as soon as you press this. The next step is optional detail that helps us formulate better.

You're in the study.

Entry logged. When we publish the next round of findings, you'll see how the numbers moved.

Follow the build

Get the findings before the product exists

About once a month, when there's something worth sharing: what the research is turning up, which ingredients made the cut and which got dropped, real cost breakdowns, and every community vote before it closes.

No selling your data, no daily blasts. One click to leave, any time.
Updates are research notes, not medical advice. Important disclosures.